[Form 4] C.H. Robinson Worldwide, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Rajan Arun, Chief Strategy & Innovation Officer of C.H. Robinson Worldwide, Inc. (CHRW), reported a sale of 2,500 shares of common stock on 08/15/2025 at a price of $121.74 per share. The filing states the sale was made pursuant to a 10b5-1(c) plan adopted on 05/08/2025. After the reported transaction, the reporting person beneficially owns 130,591 shares, which the filing explains include 91,210 shares issuable on settlement of restricted stock units and deferred shares credited to a NQDC plan account and 38,994 shares held directly; an additional 387 shares were acquired under the employee stock purchase plan. The form is signed by an attorney-in-fact and contains only the insider transaction and ownership breakdown disclosed above.

Positive

• Transaction executed under a documented 10b5-1 plan adopted 05/08/2025, indicating pre-planned trading and compliance with insider trading procedures
• Substantial remaining ownership of 130,591 shares, largely composed of restricted stock units and deferred shares, which supports ongoing alignment with shareholder interests

Negative

• Officer sold 2,500 shares on 08/15/2025 at $121.74 per share; while disclosed, the filing does not provide context on whether the sale affects compensation or diversification plans

Insights

Financial Analyst

TL;DR Insider sale of 2,500 shares under a 10b5-1 plan; substantial remaining ownership of 130,591 shares maintains alignment with shareholders.

The sale recorded on 08/15/2025 at $121.74 per share was executed under a documented 10b5-1 plan adopted 05/08/2025, which indicates pre-planned disposition rather than opportunistic trading. Post-transaction beneficial ownership of 130,591 shares includes a large portion held in restricted stock units and deferred compensation, suggesting continued long-term exposure to company equity. The transaction size (2,500 shares) is small relative to the reported total holdings and does not, by itself, indicate a material change in insider alignment.

Corporate Governance Expert

TL;DR Use of a formal 10b5-1 plan and attorney-in-fact signature reflects procedural compliance and documentation of the insider trade.

The filing documents adoption of a 10b5-1(c) trading plan on 05/08/2025 and a transaction completed under that plan on 08/15/2025. The signature by an attorney-in-fact is consistent with delegated execution. The disclosure of amounts held in restricted stock units, deferred accounts, and ESPP shares provides transparent reporting of indirect and direct ownership. From a governance perspective these elements indicate adherence to standard insider trading controls and disclosure practices.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

RAJAN ARUN

(Last) (First) (Middle)

14701 CHARLSON ROAD

(Street)

EDEN PRAIRIE MN 55347

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
C. H. ROBINSON WORLDWIDE, INC. [ CHRW ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Strat & Innov Officer

3. Date of Earliest Transaction (Month/Day/Year)
08/15/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/15/2025		S(1)		2,500	D	$121.74	130,591(2)(3)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Adoption date of referenced 10b5-1(c) plan is: 05-08-2025

2. Included in this amount are 91,210 shares of Issuer common stock issuable in settlement of an equal number of restricted stock units and deferred shares credited to the reporting person's NQDC Plan account and 38,994 shares held directly by the reporting person.

3. Includes 387 shares acquired pursuant to the Issuer's employee stock purchase plan.

	/s/ Nicole Strydom, Attorney-in-Fact for Arun Rajan	08/19/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did CHRW insider Rajan Arun report on Form 4?

The filing reports a sale of 2,500 shares on 08/15/2025 at $121.74 per share and shows 130,591 shares beneficially owned after the transaction.

Was the sale by Rajan Arun part of a trading plan?

Yes. The sale was reported as made pursuant to a 10b5-1(c) plan adopted on 05/08/2025.

How is the 130,591 shares of reported ownership composed?

The filing states it includes 91,210 shares issuable upon settlement of restricted stock units and deferred shares in a NQDC plan account, 38,994 shares held directly, and 387 shares acquired via the employee stock purchase plan.

What position does the reporting person hold at CHRW?

The reporting person is listed as Chief Strategy & Innovation Officer and an officer of the issuer.

Who signed the Form 4 on behalf of Rajan Arun?

The Form 4 is signed by Nicole Strydom, Attorney-in-Fact for Arun Rajan with signature date 08/19/2025.